Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Isis Pharma launches phase II program for ISIS-EIF4ERx in cancer

Jan. 5, 2011

New inhibitors of serine/threonine-protein kinase 6 discovered

Jan. 5, 2011

Spectrum Pharma submits sNDA to FDA for Fusilev in colorectal cancer

Jan. 5, 2011

FdUMP[10] is active against acute myeloid leukemia in vitro and in vivo

Jan. 5, 2011

Mechanism of action of darinaparsin in Hodgkin's and T-cell lymphomas clarified

Jan. 5, 2011

NICE recommends approval of Votrient as first-line therapy for kidney cancer

Jan. 5, 2011

POL-6326 is well tolerated and effectively mobilizes hematopoietic stem cells in phase II trial

Jan. 4, 2011

Senesco's SNS01-T obtains FDA orphan drug status in multiple myeloma

Jan. 4, 2011

OSI scientists discover novel anticancer FADK 1 inhibitors

Jan. 4, 2011

KPT-127 is toxic to hematological cancer cells

Jan. 4, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...